WallStreetZenWallStreetZen

NASDAQ: IRMD
Iradimed Corp Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Iradimed earnings were $23.1M for the trailing 12 months ending Jun 30, 2026, with 11.7% growth year over year. The latest IRMD earnings report on Jun 30, 2026 announced Q2 2026 earnings of $5.2M, down 10.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, IRMD reported annual earnings of $22.5M, with 16.9% growth. The next IRMD earnings date is Nov 2, 2026.

IRMD past earnings growth

How has IRMD's earnings growth performed historically?

Company
11.66%
Industry
-2.82%
Market
95.3%
IRMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
IRMD's earnings have grown faster... subscribe to Premium to read more.
Earnings Growth vs Market Performance
IRMD's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

IRMD earnings history

Current Revenue
$86.3M
Current Earnings
$23.1M
Current Profit Margin
26.7%
IRMD's has demonstrated consistent long-term... subscribe to Premium to read more.
Long-term Earnings Growth Trend Performance

IRMD Return on Equity

Current Company
23.5%
Current Industry
-7%
Current Market
30.9%
IRMD's Return on Equity (23.5%)... subscribe to Premium to read more.
High Return on Equity Performance

IRMD Return on Assets

Current Company
20.4%
Current Industry
5.3%
IRMD is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when IRMD announces earnings.

IRMD Return on Capital Employed

Current Company
28.11%
Current Industry
9.6%
IRMD has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

IRMD vs Medical Device Stocks

TickerEBITDAEarningsY/Y EarningsEPS
IRMD$31.37M$23.05M+37.52%$1.82
ENOV-$741.56M-$1.10BN/A-$19.27
TNDM-$34.24M-$63.32MN/A-$0.92
BVS$96.75M$54.46MN/A$0.81
AORT$56.34M-$3.17MN/A-$0.05
View Top Medical Device Stocks

IRMD earnings dates

Next earnings date
Nov 2, 2026

Iradimed Earnings Reports & History FAQ

What were Iradimed's earnings last quarter?

On IRMD's earnings call on Jul 31, 2026, Iradimed (NASDAQ: IRMD) reported Q2 2026 earnings per share (EPS) of $0.41, up 8.89% year over year. Total IRMD earnings for the quarter were $5.22 million. In the same quarter last year, Iradimed's earnings per share (EPS) was $0.45.

If you're new to stock investing, here's how to buy Iradimed stock.

When does Iradimed report earnings?

The next IRMD earnings call is Nov 2, 2026. Add IRMD to your watchlist to be reminded of Iradimed's next earnings date.

Is Iradimed profitable or losing money?

As of the last Iradimed earnings report, Iradimed is currently profitable. Iradimed's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $23.05 million, a 11.61% increase year over year.

What was IRMD's earnings growth in the past year?

As of Iradimed's earnings date in Jul 31, 2026, Iradimed's earnings has grown 11.66% year over year. This is 14.48 percentage points higher than the US Medical Devices industry earnings growth rate of -2.82%. IRMD earnings in the past year totalled $23.05 million.

What are Iradimed's earnings expectations?

The current EPS estimate for Iradimed's earnings report in Nov 2, 2026 is $0.52.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.